Found: 9
Select item for more details and to access through your institution.
A gene expression signature of Retinoblastoma loss-of-function predicts resistance to neoadjuvant chemotherapy in ER-positive/HER2-positive breast cancer patients.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 170, n. 2, p. 329, doi. 10.1007/s10549-018-4766-2
- By:
- Publication type:
- Article
Circulating tumor cells and palbociclib treatment in patients with ER-positive, HER2-negative advanced breast cancer: results from a translational sub-study of the TREnd trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
An RB-1 loss of function gene signature as a tool to predict response to neoadjuvant chemotherapy plus anti-HER2 agents: a substudy of the NeoALTTO trial (BIG 1-06).
- Published in:
- Therapeutic Advances in Medical Oncology, 2019, v. 11, p. N.PAG, doi. 10.1177/1758835919891608
- By:
- Publication type:
- Article
Cyclin E1 and Rb modulation as common events at time of resistance to palbociclib in hormone receptor-positive breast cancer.
- Published in:
- NPJ Breast Cancer, 2018, v. 4, n. 1, p. N.PAG, doi. 10.1038/s41523-018-0092-4
- By:
- Publication type:
- Article
Endocrine therapy considerations in postmenopausal patients with hormone receptor positive, human epidermal growth factor receptor type 2 negative advanced breast cancers.
- Published in:
- BMC Medicine, 2015, v. 13, n. 1, p. 1, doi. 10.1186/s12916-015-0280-0
- By:
- Publication type:
- Article
Endocrine therapy considerations in postmenopausal patients with hormone receptor positive, human epidermal growth factor receptor type 2 negative advanced breast cancers.
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
Circulating Biomarkers of CDK4/6 Inhibitors Response in Hormone Receptor Positive and HER2 Negative Breast Cancer.
- Published in:
- Cancers, 2021, v. 13, n. 11, p. 2640, doi. 10.3390/cancers13112640
- By:
- Publication type:
- Article
Pure estrogen receptor antagonists potentiate capecitabine activity in ESR1-mutant breast cancer.
- Published in:
- NPJ Breast Cancer, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41523-024-00647-1
- By:
- Publication type:
- Article
Mechanisms of Resistance to CDK4/6 Inhibitors in Breast Cancer and Potential Biomarkers of Response.
- Published in:
- Breast Care, 2017, v. 12, n. 5, p. 304, doi. 10.1159/000484167
- By:
- Publication type:
- Article